Cargando…
Improving knowledge of psychotropic prescribing in people with Intellectual Disability in primary care
PURPOSE: People with Intellectual disability (ID) are likely to be prescribed psychotropic medication particularly antipsychotics without a clear clinical indication. This has given rise to a national initiative in the UK to stop overprescribing medication in this vulnerable population. While the go...
Autores principales: | Shankar, Rohit, Wilcock, Mike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138382/ https://www.ncbi.nlm.nih.gov/pubmed/30216381 http://dx.doi.org/10.1371/journal.pone.0204178 |
Ejemplares similares
-
Pharmacogenomics: an opportunity for personalised psychotropic prescribing in adults with intellectual disabilities
por: Perera, Bhathika, et al.
Publicado: (2022) -
COVID-19 pandemic impact on psychotropic prescribing for adults with intellectual disability: an observational study in English specialist community services
por: Naqvi, Danial, et al.
Publicado: (2021) -
Changes over a decade in psychotropic prescribing for people with intellectual disabilities: prospective cohort study
por: Henderson, Angela, et al.
Publicado: (2020) -
UK psychiatrists’ experience of withdrawal of antipsychotics prescribed for challenging behaviours in adults with intellectual disabilities and/or autism
por: Deb, Shoumitro, et al.
Publicado: (2020) -
De-Prescribing of Psychotropic Medications in the Adult Population with Intellectual Disabilities: A Commentary
por: Flood, Bernadette
Publicado: (2018)